693 results on '"Saelens, Xavier"'
Search Results
202. CTA1‐3M2e‐DD; a universal influenza vaccine
203. Proteome-wide Identification of HtrA2/Omi Substrates
204. Necrosis is associated with IL-6 production but apoptosis is not
205. A Novel Caspase-2 Complex Containing TRAF2 and RIP1
206. INCA, a Novel Human Caspase Recruitment Domain Protein That Inhibits Interleukin-1β Generation
207. Caspase-1 Activates Nuclear Factor of the κ-Enhancer in B Cells Independently of Its Enzymatic Activity
208. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing
209. Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production
210. Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death Domain Protein FADD
211. Bcl-2 Family Members as Sentinels of Cellular Integrity and Role of Mitochondrial Intermembrane Space Proteins in Apoptotic Cell Death
212. The Use of Proteomics to Identify and Characterize Cell Death Proteins
213. Proteolysis of Enteric Cell Villin by Entamoeba histolytica Cysteine Proteinases
214. Mitochondrial intermembrane proteins in cell death
215. Fas-Induced Necrosis.
216. Soluble recombinant influenza vaccines
217. Translation Inhibition in Apoptosis
218. Use of HDEL-taggedTrichoderma reeseimannosyl oligosaccharide 1,2-α-D-mannosidase forN-glycan engineering inPichia pastoris
219. A universal influenza A vaccine based on the extracellular domain of the M2 protein
220. Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin
221. Single-domain antibodies make a difference.
222. In vitro Conversion of the Carbohydrate Moiety of Fungal Glycoproteins to Mammalian-type Oligosaccharides. Evidence for N -acetylglucosaminyltransferase-I-accepting Glycans from Trichoderma reesei
223. Protection of Mice Against a Lethal Influenza Challenge by Immunization with Yeast-Derived Recombinant Influenza Neuraminidase
224. How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.
225. A Fairly Conserved Epitope on the Hemagglutinin of Influenza A (H3N2) Virus with Variable Accessibility to Neutralizing Antibody
226. Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e.
227. Hepatitis B core-based virus-like particles to present heterologous epitopes.
228. Influenza vaccines: T-cell responses deserve more attention.
229. The Sin3a repressor complex is a master regulator of STAT transcriptional activity.
230. The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections.
231. Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection.
232. Role of IFN-α during the acute stage of a swine influenza virus infection
233. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.
234. The influenza matrix protein 2 as a vaccine target.
235. Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1.
236. Protein synthesis persists during necrotic cell death.
237. Toxic proteins released from mitochondria in cell death.
238. Bcl-2 Family Members as Sentinels of Cellular Integrity and Role of Mitochondrial Intermembrane Space Proteins in Apoptotic Cell Death.
239. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
240. Cov2MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein
241. Modification of the protein glycosylation pathway in the methylotrophic yeast Pichia pastoris.
242. <em>In vitro</em> conversion of the carbohydrate moiety of fungal glycoproteins to mammalian-type oligosaccharides.
243. An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
244. Use of HDEL‐tagged Trichoderma reeseimannosyl oligosaccharide 1,2‐α‐D‐mannosidase for N‐glycan engineering in Pichia pastoris
245. In VivoTherapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
246. An Inside Job: Applications of Intracellular Single Domain Antibodies.
247. Cell-Mediated Responses to Human Metapneumovirus Infection.
248. Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation.
249. New antibody-based prevention and treatment options for influenza.
250. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.